Spiracur takes $20.3M for effective wound healing
Spiracur, developer of a device used to heal small wounds effectively, has brought in $20.3 million in a second round of funding from Kleiner Perkins Caufield & Byers, New Leaf Venture Partners and De Novo Ventures, reports VentureWire. Not much is known about the Redwood City, Calif., company’s technology.
Spiracur has raised $24.3 million since its inception in 2007. It is based on technology developed in a bio-design program at Stanford University.
Next Story: Cyan Optics sees $8.8M for optical communications systems
Previous Story: ICANN has Rod Beckstrom as new president and CEO?
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.